Home RxNorm 1738541 betamethasone 0.5 MG/ML Topical Spray [Sernivo] Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1738541
RxNorm name betamethasone 0.5 MG/ML Topical Spray [Sernivo]
Display name SERNIVO (Topical)
Full name betamethasone 0.5 MG/ML Topical Spray [Sernivo]
Term type SBD
Status Active
Strength 0.05%
Dose form Spray
Route Topical
Updated 2026-10-21 07:31:05 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 032016
Active start 032016
Multiple ingredient NO
Branded YES Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength betamethasone dipropionate 0.5 MG / 1 ML betamethasone betamethasone
Derived Ingredient Concepts# FDA NDC Products And Packages# Package NDC, Product NDC, Name table Package NDC Product NDC Name Labeler Application 68040-714-08 68040-714 Sernivo betamethasone dipropionate Primus Pharmaceuticals, Inc. NDA208079 68040-714-28 68040-714 Sernivo betamethasone dipropionate Primus Pharmaceuticals, Inc. NDA208079
Drugs@FDA Applications# Application, NDC, Name table Application NDC Name Marketing category Labeler NDA208079 68040-714 Sernivo betamethasone dipropionate NDA Primus Pharmaceuticals, Inc.
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 6 matching rows.
NDC11, Source, Active table NDC11 Source Active 67857080804 rxnav_ndcs yes 68040071408 rxnav_ndcs yes 68040071428 rxnav_ndcs yes 69482080099 rxnav_ndcs yes 67857080817 rxnav_historical 68040071499 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective b1b3d1b0-da9b-11eb-ad76-0800200c9a66 Sernivo 0.05 % Topical Spray [PSN] · betamethasone 0.5 MG/ML Topical Spray [Sernivo] [SBD] · Sernivo 0.05 % Topical Spray [SY] · Sernivo 0.5 MG/ML Topical Spray [SY] 4 7 These highlights do not include all the information needed to use SERNIVO ™ Spray safely and effectively. See full prescribing information for SERNIVO ™ Spray. SERNIVO ™ (betamethasone dipropionate) spray, for topical use Initial U.S. Approval: 1975 20260422
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective b1b3d1b0-da9b-11eb-ad76-0800200c9a66 These highlights do not include all the information needed to use SERNIVO ™ Spray safely and effectively. See full prescribing information for SERNIVO ™ Spray. SERNIVO ™ (betamethasone dipropionate) spray, for topical use Initial U.S. Approval: 1975 Primus Pharmaceuticals, Inc. | Symbiotec Pharmalab Private Limited 20260422 21ca2c66-4ad1-4b6a-9c81-77d89eeb9edd These highlights do not include all the information needed to use SERNIVO™ Spray safely and effectively. See full prescribing information for SERNIVO™ Spray. SERNIVO™ (betamethasone dipropionate) spray, for topical use Initial U.S. Approval: 1975 Encore Dermatology Inc. | Crystal Pharma, S.A 20200727 590cee5b-2712-4da6-99fe-5e14b44f2597 These highlights do not include all the information needed to use SERNIVO ® Spray safely and effectively. See full prescribing information for SERNIVO ® Spray. SERNIVO ® (betamethasone dipropionate) Spray, for 0.05% for topical use Initial U.S. Approval: 1975 Promius Pharma, LLC | Crystal Pharma S.A.U. | DPT Laboratories, Ltd. | Sharp Corporation 20181130
Drug Classes# Source, Class ID, Class table Source Class ID Class Type Relationship Drug concept ATC C05AA Corticosteroids ATC1-4 betamethasone ATC S03BA Corticosteroids ATC1-4 betamethasone ATC S02BA Corticosteroids ATC1-4 betamethasone ATC R01AD Corticosteroids ATC1-4 betamethasone ATC A07EA Corticosteroids acting locally ATC1-4 betamethasone ATC S01BA Corticosteroids, plain ATC1-4 betamethasone ATC D07AC Corticosteroids, potent (group III) ATC1-4 betamethasone ATC D07XC Corticosteroids, potent, other combinations ATC1-4 betamethasone ATC S01CB Corticosteroids/antiinfectives/mydriatics in combination ATC1-4 betamethasone ATC R03BA Glucocorticoids ATC1-4 betamethasone ATC H02AB Glucocorticoids ATC1-4 betamethasone FDASPL N0000175576 Corticosteroid EPC has_epc betamethasone FDASPL N0000175450 Corticosteroid Hormone Receptor Agonists MOA has_moa betamethasone MEDRT D001623 Betamethasone CHEM has_ingredient betamethasone MEDRT D003876 Dermatitis, Atopic DISEASE may_treat betamethasone MEDRT D012628 Dermatitis, Seborrheic DISEASE may_treat betamethasone MEDRT D004342 Drug Hypersensitivity DISEASE ci_with betamethasone MEDRT D005148 Facial Dermatoses DISEASE may_treat betamethasone MEDRT D005533 Foot Dermatoses DISEASE may_treat betamethasone MEDRT D006229 Hand Dermatoses DISEASE may_treat betamethasone MEDRT D007249 Inflammation DISEASE may_treat betamethasone MEDRT D007868 Leg Dermatoses DISEASE may_treat betamethasone MEDRT D009181 Mycoses DISEASE ci_with betamethasone MEDRT D011538 Pruritus Ani DISEASE may_treat betamethasone MEDRT D011565 Psoriasis DISEASE may_treat betamethasone MEDRT D016553 Purpura, Thrombocytopenic, Idiopathic DISEASE ci_with betamethasone MEDRT D012536 Scalp Dermatoses DISEASE may_treat betamethasone MEDRT N0000000159 Glucocorticoid Receptor Agonists MOA has_moa betamethasone MEDRT N0000000134 Lipoxygenase Inhibitors MOA has_moa betamethasone MEDRT N0000008297 Antipruritic Activity PE has_pe betamethasone MEDRT N0000008327 Carbohydrate Metabolism Alteration PE has_pe betamethasone MEDRT N0000009928 Decreased Cellular Migration PE has_pe betamethasone MEDRT N0000008645 Decreased Glucocorticoid Secretion PE has_pe betamethasone MEDRT N0000008681 Decreased Leukotriene Activity PE has_pe betamethasone MEDRT N0000008700 Decreased Lysosomal Function PE has_pe betamethasone MEDRT N0000008834 Decreased Prostaglandin Activity PE has_pe betamethasone MEDRT N0000008841 Decreased Protein Synthesis PE has_pe betamethasone MEDRT N0000009004 Decreased Thromboxane Activity PE has_pe betamethasone MEDRT N0000009739 Lipid Metabolism Alteration PE has_pe betamethasone
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 0.5 MG/ML ATTRIBUTES GENERAL_CARDINALITY SINGLE ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES NDA NDA208079 NAMES Prescribable Synonym Sernivo 0.05 % Topical Spray SOURCES Source Gold Standard Alchemy SOURCES Source Metathesaurus FDA Structured Product Labels SOURCES Source Micromedex RED BOOK SOURCES Source Multum MediSource Lexicon